Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'.

Source:http://linkedlifedata.com/resource/pubmed/id/2511533

Download in:

View as

General Info

PMID
2511533